Brain Lesions Linked to Vision Loss in MS — What to Know

Credibility

Interest

Key Takeaway

Certain chronic brain lesions called paramagnetic rim lesions in the visual pathway are linked to steady, measurable damage that leads to worsening vision and overall disability in people with MS.

What They Found

Researchers used eye scans (OCT) and brain MRI to measure a new sign of nerve damage that travels backward from the brain to the eye (called retrograde trans-synaptic degeneration, or rTSD). People with MS had more of this eye-layer thinning than people without MS, meaning the disease can cause measurable loss along the visual pathway. Having paramagnetic rim lesions (PRL) in the optic radiations — a part of the brain that carries visual signals — was tied to much higher rTSD and worse visual field sensitivity, like losing part of the side of your vision. Over time, increases in rTSD were linked to small but steady drops in visual field sensitivity and higher chances of overall disability getting worse. Higher body mass index (BMI), longer MS disease duration, and being African American were also associated with more or faster rTSD in this study.

Who Should Care and Why

People with MS should care because the study shows a clear link between certain brain lesions and gradual vision loss — this helps explain why some people notice worsening vision over time. Caregivers can use this information to watch for subtle vision changes (like missing things at the edge of sight) and bring them to clinic attention sooner. Neurologists and eye doctors might use the MRI and OCT signs described to monitor disease activity and the risk of future vision or disability decline, similar to checking an engine light before a breakdown. Patients with longer disease duration, higher BMI, or who are African American may benefit from closer monitoring because the study found these factors linked to more damage. Knowing these risks can help teams plan lifestyle steps (for example, weight management) and consider treatment or monitoring changes to try to slow progression.

Important Considerations

This study found associations but cannot prove cause and effect — that means PRL and rTSD are linked, but we can’t say one definitely causes the other from this study alone. The sample had specific groups and only 170 people with MS, so results may not apply exactly the same to every person with MS. Finally, MRI and OCT measurements are specialized tests; access and how they’re read can vary, so talk with your clinic about whether these tests are available and useful for your care.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Diagnostics MS Progression Specific Symptoms

Article Topics:

multiple sclerosisparamagnetic rim lesionsretrograde trans‐synaptic degeneration

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of clinical and translational neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News